{"id":24377,"date":"2025-04-13T17:41:36","date_gmt":"2025-04-13T17:41:36","guid":{"rendered":"https:\/\/researchchemicallab.eu\/?post_type=product&#038;p=24377"},"modified":"2026-02-02T19:51:49","modified_gmt":"2026-02-02T19:51:49","slug":"maxtc-5-mapb-4-fma-5-meo-mipt","status":"publish","type":"product","link":"https:\/\/researchchemicallab.eu\/hr\/ducan\/kupiti-4fma\/maxtc-5-mapb-4-fma-5-meo-mipt\/","title":{"rendered":"MaXTC 5-MAPB\/4-FMA\/5-MeO-MiPT"},"content":{"rendered":"<h1><strong>Definicija proizvoda: MaXTC 5-MAPB \/ 4-FMA \/ 5-MeO-MiPT pelete<\/strong><\/h1>\n<p class=\"ds-markdown-paragraph\"><strong>Sastav po peleti (mikroinkapsuliranoj):<\/strong><\/p>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>5-MAPB (5-metoksi-3,4-metilendioksiamfetamin):<\/strong>\u00a060 mg<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>4-FMA (4-fluorometamfetamin):<\/strong>\u00a040 mg<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>5-MeO-MiPT (5-Metoksi-N-metil-N-izopropiltriptamin):<\/strong>\u00a05 mg<br \/>\n<strong>Oblik:<\/strong>\u00a0Ujedna\u010dene pelete s sporim osloba\u0111anjem<br \/>\n<strong>Izgled:<\/strong>\u00a0Svijetlo obojene, okrugle tablete (\u00b1 220 mg svaka)<br \/>\n<strong>CAS brojevi:<\/strong><\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\">5-MAPB: 1354631-79-7<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\">4-FMA: 351-03-1<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\">5-MeO-MiPT: 96096-55-8<\/p>\n<\/li>\n<\/ul>\n<hr \/>\n<h2><strong>Opis i mehanizam djelovanja<\/strong><\/h2>\n<p class=\"ds-markdown-paragraph\"><strong>MaXTC<\/strong>\u00a0je\u00a0<strong>sna\u017ena, uravnote\u017eena entaktogena i stimuliraju\u0107a mje\u0161avina<\/strong>, dizajniran za\u00a0<strong>kombinacija empatije, energije i blagih psihodeli\u010dnih u\u010dinaka<\/strong>.<\/p>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>5-MAPB<\/strong>\u00a0\u279c Primarni\u00a0<strong>serotonergi\u010dki empatogeni u\u010dinak<\/strong>\u00a0(sli\u010dno MDMA-u, ali bla\u017ee)<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>4-FMA<\/strong>\u00a0\u279c\u00a0<strong>Dopaminergi\u010dki\/noradrenergi\u010dki stimulans<\/strong>\u00a0za energiju i fokus<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>5-MeO-MiPT<\/strong>\u00a0\u279c\u00a0<strong>Lagana psihodeli\u010dna nijansa<\/strong>\u00a0(senzorno poja\u010danje, emocionalna dubina)<\/p>\n<\/li>\n<\/ul>\n<h3><strong>Primarni u\u010dinci:<\/strong><\/h3>\n<p class=\"ds-markdown-paragraph\">\u2714 Sna\u017eno\u00a0<strong>emocionalna povezanost<\/strong>\u00a0(sli\u010dno MDMA-u)<br \/>\n\u2714 Dugotrajno\u00a0<strong>fizi\u010dka energija<\/strong>\u00a0bez naglog sudara<br \/>\n\u2714 Suptilno\u00a0<strong>vizualno i taktilno poja\u010danje<\/strong><br \/>\n\u2714\u00a0<strong>Manje stiskanja \u010deljusti<\/strong>\u00a0nego s \u010distim stimulansima<\/p>\n<hr \/>\n<h2><strong>Primjeri upotrebe i primjene<\/strong><\/h2>\n<h3><strong>1. Dru\u0161tvena i sve\u010dana upotreba<\/strong><\/h3>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Festivali, klubovi i zabave<\/strong>\u00a0\u2013 Dugotrajna energija + empatija.<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Duboki razgovori i povezanost<\/strong>\u00a0\u2013 Manje jak od \u010distog MDMA-a.<\/p>\n<\/li>\n<\/ul>\n<h3><strong>2. Terapijske mogu\u0107nosti (eksperimentalno)<\/strong><\/h3>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\">Mogu\u0107e korisno za\u00a0<strong>emocionalna obrada<\/strong>\u00a0(nije klini\u010dki prou\u010davano).<\/p>\n<\/li>\n<\/ul>\n<h3><strong>3. Svrha istra\u017eivanja<\/strong><\/h3>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\">Studija o\u00a0<strong>kombinirani u\u010dinci entaktogena, stimulansa i triptamina<\/strong>.<\/p>\n<\/li>\n<\/ul>\n<hr \/>\n<h2><strong>Prednosti MaXTC peleta<\/strong><\/h2>\n<p class=\"ds-markdown-paragraph\">\u2705\u00a0<strong>Uravnote\u017eena &quot;Trifecta&quot; akcija<\/strong><br \/>\n\u2192 Empatija (5-MAPB) + Energija (4-FMA) + Senzorna dubina (5-MeO-MiPT)<\/p>\n<p class=\"ds-markdown-paragraph\">\u2705\u00a0<strong>Dulje trajanje djelovanja (~6-8 sati)<\/strong><br \/>\n\u2192 Potrebno je manje ponovljenih doza.<\/p>\n<p class=\"ds-markdown-paragraph\">\u2705\u00a0<strong>Manje &quot;kompromisa&quot; nego MDMA<\/strong><br \/>\n\u2192 Zahvaljuju\u0107i postupnom otpu\u0161tanju.<\/p>\n<p class=\"ds-markdown-paragraph\">\u2705\u00a0<strong>Precizno dozirano<\/strong><br \/>\n\u2192 Smanjuje rizik od predoziranja.<\/p>\n<hr \/>\n<h2><strong>Nedostaci i rizici<\/strong><\/h2>\n<p class=\"ds-markdown-paragraph\">\u274c\u00a0<strong>Nema klini\u010dkih podataka<\/strong>\u00a0\u2192 Nepoznati dugoro\u010dni rizici.<br \/>\n\u274c\u00a0<strong>Mogu\u0107e nuspojave:<\/strong><\/p>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Lupanje srca<\/strong>\u00a0(od 4-FMA)<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Blaga anksioznost<\/strong>\u00a0(5-MeO-MiPT u vi\u0161im dozama)<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Dehidracija<\/strong>\u00a0(zbog stimuliraju\u0107eg u\u010dinka)<br \/>\n\u274c\u00a0<strong>Potencijalno zarazno<\/strong>\u00a0\u2192 Dopaminski u\u010dinak 4-FMA mo\u017ee uzrokovati \u017eudnju.<\/p>\n<\/li>\n<\/ul>\n<hr \/>\n<h2><strong>Preporu\u010dena doza i uporaba<\/strong><\/h2>\n<p class=\"ds-markdown-paragraph\">\u26a0\u00a0<strong>Upozorenje:<\/strong>\u00a0Samo u istra\u017eiva\u010dke svrhe.\u00a0<strong>Nije za ljudsku konzumaciju.<\/strong><\/p>\n<div class=\"markdown-table-wrapper\">\n<table>\n<thead>\n<tr>\n<th>Cilj<\/th>\n<th>Doziranje<\/th>\n<th>Trajanje u\u010dinka<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><strong>Blagi u\u010dinci<\/strong><\/td>\n<td>\u00bd peleta (~30 mg 5-MAPB \/ 20 mg 4-FMA \/ 2,5 mg 5-MeO-MiPT)<\/td>\n<td>5-6 sati<\/td>\n<\/tr>\n<tr>\n<td><strong>Standardna doza<\/strong><\/td>\n<td><strong>1 peleta (60\/40\/5 mg)<\/strong><\/td>\n<td>6-8 sati<\/td>\n<\/tr>\n<tr>\n<td><strong>Iskusni korisnici<\/strong><\/td>\n<td>Maks.\u00a0<strong>1,5 peleta (90\/60\/7,5 mg)<\/strong><\/td>\n<td>8+ sati (ne preporu\u010duje se po\u010detnicima)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p class=\"ds-markdown-paragraph\"><strong>Administracija:<\/strong><\/p>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Samo usmeno<\/strong>\u00a0(ne \u0161mrkati\/ubrizgavati).<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\">Operacija po\u010dinje nakon\u00a0<strong>~45-60 minuta<\/strong>.<\/p>\n<\/li>\n<\/ul>\n<p class=\"ds-markdown-paragraph\"><strong>Savjeti za sigurnu upotrebu:<\/strong><\/p>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Hidrat<\/strong>\u00a0(ali ne pretjerano).<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Uzimajte pauze<\/strong>\u00a0(min. 4-6 tjedana izme\u0111u upotreba).<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Koristite u sigurnom okru\u017eenju<\/strong>\u00a0(po mogu\u0107nosti s \u010duvarom putnika).<\/p>\n<\/li>\n<\/ul>\n<hr \/>\n<h2><strong>\u010cesto postavljana pitanja (FAQs)<\/strong><\/h2>\n<h3><strong>1. Je li MaXTC legalan u Nizozemskoj?<\/strong><\/h3>\n<p class=\"ds-markdown-paragraph\">\u2192\u00a0<strong>Vjerojatno ilegalno<\/strong>\u00a0prema Zakonu o opijumu (sve komponente su regulirane ili su siva zona).<\/p>\n<h3><strong>2. Po \u010demu se ovo razlikuje od obi\u010dnog ecstasyja\/MDMA-a?<\/strong><\/h3>\n<p class=\"ds-markdown-paragraph\">\u2192\u00a0<strong>Manje eufori\u010dno, ali uravnote\u017eenije<\/strong>\u00a0(manje \u201ekotrljanja\u201c, vi\u0161e kontrolirane energije).<\/p>\n<h3><strong>3. Mogu li ovo kombinirati s alkoholom ili drugim drogama?<\/strong><\/h3>\n<p class=\"ds-markdown-paragraph\">\u2192\u00a0<strong>Apsolutno se ne preporu\u010duje!<\/strong><\/p>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Alkohol<\/strong>\u00a0\u2192 Pove\u0107ana dehidracija\/toksi\u010dnost.<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Psihoaktivne tvari<\/strong>\u00a0\u2192 Nepredvidive interakcije.<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>MAO inhibitori<\/strong>\u00a0\u2192\u00a0<strong>Iznimno opasno!<\/strong><\/p>\n<\/li>\n<\/ul>\n<h3><strong>4. Postoji li rizik od serotoninskog sindroma?<\/strong><\/h3>\n<p class=\"ds-markdown-paragraph\">\u2192\u00a0<strong>Teoretski mogu\u0107e<\/strong>\u00a0kombinacijom 5-MAPB + 5-MeO-MiPT \u2192\u00a0<strong>Ne kombinirati sa SSRI\/MAO inhibitorima!<\/strong><\/p>\n<h3><strong>5. Kakav je osje\u0107aj nakon sloma?<\/strong><\/h3>\n<p class=\"ds-markdown-paragraph\">\u2192\u00a0<strong>Bla\u017ee od MDMA-a<\/strong>\u00a0(manje emocionalnog pada), ali ne\u0161to iskustva\u00a0<strong>blagi umor\/pote\u0161ko\u0107e sa spavanjem<\/strong>.<\/p>\n<hr \/>\n<h2><strong>Laboratorijsko izvje\u0161\u0107e i kontrola kvalitete<\/strong><\/h2>\n<p class=\"ds-markdown-paragraph\"><strong>Analiza standardne serije:<\/strong><\/p>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>\u010cisto\u0107a:<\/strong><\/p>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\">5-MAPB: \u226597%<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\">4-FMA: \u226595%<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\">5-MeO-MiPT: \u226598%<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Preostala otapala:<\/strong>\u00a0&lt;1%<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Konzistentnost doziranja:<\/strong>\u00a0Varijacija \u00b13% po kuglici<\/p>\n<\/li>\n<\/ul>\n<p class=\"ds-markdown-paragraph\"><strong>Stabilnost:<\/strong><\/p>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong>Rok trajanja:<\/strong>\u00a0<strong>18-24 mjeseca<\/strong>\u00a0(\u010duvati na hladnom, tamnom i suhom mjestu).<\/p>\n<\/li>\n<\/ul>\n<hr \/>\n<h2><strong>Zaklju\u010dak i sigurnosni savjeti<\/strong><\/h2>\n<p class=\"ds-markdown-paragraph\"><strong>MaXTC<\/strong>\u00a0je\u00a0<strong>sna\u017ena, svestrana mje\u0161avina<\/strong>\u00a0za one koji tra\u017ee\u00a0<strong>alternativa tradicionalnim empatogenima<\/strong>, ali zbog\u00a0<strong>nepoznati rizici<\/strong>\u00a0je\u00a0<strong>krajnji oprez<\/strong>\u00a0ponu\u0111eno.<\/p>\n<p class=\"ds-markdown-paragraph\">\u26a0\u00a0<strong>ODRICANJE:<\/strong>\u00a0Ovaj proizvod je\u00a0<strong>samo u istra\u017eiva\u010dke svrhe<\/strong>\u00a0i\u00a0<strong>nije namijenjeno za ljudsku prehranu<\/strong>.<a href=\"https:\/\/researchchemicallab.eu\/hr\/ducan\/iboga-ibogain\/kupiti-ibogain-hidroklorid-online\/\">kupiti ibogain hidroklorid online<\/a><a href=\"https:\/\/researchchemicallab.eu\/hr\/ducan\/iboga-ibogain\/kora-korijena-iboge\/\">kora korijena iboge<\/a><a href=\"https:\/\/researchchemicallab.eu\/hr\/ducan\/lisergamidi\/1cp-lsd-a\/\">1cp LSD-a<\/a><a href=\"https:\/\/researchchemicallab.eu\/hr\/ducan\/pelete-za-pelete\/o-dsmt-50-mg-pelete\/\">o-dsmt<\/a><a href=\"https:\/\/researchchemicallab.eu\/hr\/ducan\/lisergamidi\/1vlsd\/\">1vlsd<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Definicija proizvoda: MaXTC 5-MAPB \/ 4-FMA \/ 5-MeO-MiPT pelete Sastav po peleti (mikrokapsulirano): 5-MAPB (5-metoksi-3,4-metilendioksiamfetamin): 60 mg 4-FMA (4-fluorometamfetamin): 40 mg 5-MeO-MiPT (5-metoksi-N-metil-N-izopropiltriptamin): 5<\/p>","protected":false},"featured_media":29064,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[459,460,383,433,436,434,339,322,333,467,468,324,381],"product_tag":[664,326],"class_list":{"0":"post-24377","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-4fma-kopen","7":"product_cat-4-fma-pellets","8":"product_cat-5-mapb","9":"product_cat-5-mapb-pellets","10":"product_cat-5-meo-mipt","11":"product_cat-5-meo-mipt-pellets","12":"product_cat-benzofuran","13":"product_cat-bijna-verboden","14":"product_cat-gefluoreerden","15":"product_cat-maxtc","16":"product_cat-maxtc-pellets","17":"product_cat-pellets-for-pellet","18":"product_cat-tryptamines","19":"product_tag-maxtc","20":"product_tag-nl","22":"first","23":"instock","24":"taxable","25":"shipping-taxable","26":"purchasable","27":"product-type-variable"},"_links":{"self":[{"href":"https:\/\/researchchemicallab.eu\/hr\/wp-json\/wp\/v2\/product\/24377","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/researchchemicallab.eu\/hr\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/researchchemicallab.eu\/hr\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/researchchemicallab.eu\/hr\/wp-json\/wp\/v2\/comments?post=24377"}],"version-history":[{"count":4,"href":"https:\/\/researchchemicallab.eu\/hr\/wp-json\/wp\/v2\/product\/24377\/revisions"}],"predecessor-version":[{"id":26501,"href":"https:\/\/researchchemicallab.eu\/hr\/wp-json\/wp\/v2\/product\/24377\/revisions\/26501"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/researchchemicallab.eu\/hr\/wp-json\/wp\/v2\/media\/29064"}],"wp:attachment":[{"href":"https:\/\/researchchemicallab.eu\/hr\/wp-json\/wp\/v2\/media?parent=24377"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/researchchemicallab.eu\/hr\/wp-json\/wp\/v2\/product_brand?post=24377"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/researchchemicallab.eu\/hr\/wp-json\/wp\/v2\/product_cat?post=24377"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/researchchemicallab.eu\/hr\/wp-json\/wp\/v2\/product_tag?post=24377"}],"curies":[{"name":"radni list","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}